Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page
- Check5 days agoChange DetectedThe page now shows expanded access and posted results, plus a full suite of clinician- and caregiver-rated outcome measures through week 20 with independent ratings, while older endpoints like 22-week data and certain walk/run tests have been removed.SummaryDifference34%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of new resources related to genetic diseases and drug safety, while removing previous references to certain locations and genetic conditions.SummaryDifference3%
- Check26 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.4%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.